Evidence map›Paper›PMID 36322190›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

Brain

François Goehringer, Alexandra Bruyere, Matthieu Doyen, Sibylle Bevilacqua, Alexandre Charmillon, Sebastien Heyer, Antoine Verger

Open access · bronzeAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. BrainEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Mechanisms of long COVID: An updated review.Chinese medical journal pulmonary and critical care medicine · 2023
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

François Goehringer *Department of Infectious Diseases, CHRU Nancy, 54000, Nancy, France.
Alexandra Bruyere *Department of Infectious Diseases, CHRU Nancy, 54000, Nancy, France.
Matthieu DoyenDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, 54000, Nancy, France.
Sibylle BevilacquaDepartment of Infectious Diseases, CHRU Nancy, 54000, Nancy, France.
Alexandre CharmillonDepartment of Infectious Diseases, CHRU Nancy, 54000, Nancy, France.
Sebastien HeyerDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, 54000, Nancy, France.
Antoine VergerDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, 54000, Nancy, France. a.verger@chru-nancy.fr.ORCID 0000-0003-2194-0328
Centre Hospitalier Régional et Universitaire de Nancy · FRInserm · FRUniversité de Lorraine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBrain

methodsWe retrospectively included 28 consecutive outpatients who presented with post-COVID-19 conditions between September 2020 and May 2022 and who satisfied the WHO definition, and had a brain

resultsOutpatients with post-COVID-19 conditions exhibited diffuse hypometabolism predominantly involving right frontal and temporal lobes including the orbito-frontal cortex and internal temporal areas. Metabolism in these clusters was inversely correlated with the number of symptoms during the initial infection (r =  - 0.44, p = 0.02) and with the duration of symptoms (r =  - 0.39, p = 0.04). Asthenia and cardiovascular, digestive, and neurological disorders during the acute phase and asthenia and language disorders during the chronic phase (p ≤ 0.04) were associated with these hypometabolic clusters.

conclusionOutpatients with post-COVID-19 conditions exhibited extensive hypometabolic right fronto-temporal clusters. Patients with more numerous symptoms during the initial phase and with a longer duration of symptoms were at higher risk of persistent brain involvement.

Indexed as

COVID-19Fluorodeoxyglucose F18AstheniaBrainHumansOutpatientsPositron-Emission TomographyRetrospective StudiesFluorodeoxyglucose F18Brain involvementCOVID-19FDG PETLong COVIDNon-hospitalizedOutpatientsPETPost-COVID-19 conditions

Identifiers

PMID36322190
PMCPMC9628394
OpenAlexW4308160670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.